[go: up one dir, main page]

DE69707497D1 - BENZOPYRANOPYRROLE AND BENZOPYRANOPYRIDINE WITH ALPHA-1 ADRENERGIC EFFECT - Google Patents

BENZOPYRANOPYRROLE AND BENZOPYRANOPYRIDINE WITH ALPHA-1 ADRENERGIC EFFECT

Info

Publication number
DE69707497D1
DE69707497D1 DE69707497T DE69707497T DE69707497D1 DE 69707497 D1 DE69707497 D1 DE 69707497D1 DE 69707497 T DE69707497 T DE 69707497T DE 69707497 T DE69707497 T DE 69707497T DE 69707497 D1 DE69707497 D1 DE 69707497D1
Authority
DE
Germany
Prior art keywords
alpha
benzopyranopyrrole
benzopyranopyridine
adrenergic effect
bph
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69707497T
Other languages
German (de)
Other versions
DE69707497T2 (en
Inventor
D Meyer
J Altenbach
Fatima Basha
A Carroll
Irene Drizin
F Kerwin
D Wendt
R Haight
Weijiang Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/980,130 external-priority patent/US6046207A/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69707497D1 publication Critical patent/DE69707497D1/en
Publication of DE69707497T2 publication Critical patent/DE69707497T2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

The present invention relates to a compound of formula (I) and the pharmaceutically acceptable salts thereof wherein W is a bicyclic heterocyclic ring system. The compounds are alpha -1 adrenergic antagonists and are useful in the treatment of BPH; also disclosed are alpha -1 antagonist compositions and a method for antagonizing alpha -1 adrenoreceptors and treating BPH.
DE69707497T 1996-12-06 1997-12-04 BENZOPYRANOPYRROLE AND BENZOPYRANOPYRIDINE WITH ALPHA-1 ADRENERGIC EFFECT Expired - Fee Related DE69707497T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76142396A 1996-12-06 1996-12-06
US08/980,130 US6046207A (en) 1996-12-06 1997-11-26 Benzopyranopyrrole and benzopyranopyridine α-1 adrenergic compounds
PCT/US1997/022279 WO1998024791A1 (en) 1996-12-06 1997-12-04 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds

Publications (2)

Publication Number Publication Date
DE69707497D1 true DE69707497D1 (en) 2001-11-22
DE69707497T2 DE69707497T2 (en) 2002-07-11

Family

ID=27116981

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69707497T Expired - Fee Related DE69707497T2 (en) 1996-12-06 1997-12-04 BENZOPYRANOPYRROLE AND BENZOPYRANOPYRIDINE WITH ALPHA-1 ADRENERGIC EFFECT

Country Status (19)

Country Link
EP (1) EP0942911B1 (en)
JP (1) JP2002504088A (en)
KR (1) KR20000057418A (en)
CN (1) CN1130365C (en)
AT (1) ATE207071T1 (en)
AU (1) AU735764B2 (en)
BG (1) BG63975B1 (en)
CA (1) CA2272330A1 (en)
CY (1) CY2260B1 (en)
CZ (1) CZ194499A3 (en)
DE (1) DE69707497T2 (en)
DK (1) DK0942911T3 (en)
ES (1) ES2168682T3 (en)
NO (1) NO992661L (en)
NZ (1) NZ335711A (en)
PT (1) PT942911E (en)
SK (1) SK283580B6 (en)
TR (1) TR199901883T2 (en)
WO (1) WO1998024791A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999019314A1 (en) * 1997-10-10 1999-04-22 Abbott Laboratories Process for preparing substituted pyrazine compounds
TW536402B (en) 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
UA69420C2 (en) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. TRICYCLIC D3-PIPERIDINES AS a<sub>2-ANTAGONISTS
PL347179A1 (en) * 1998-10-06 2002-03-25 Janssen Pharmaceutica Nv Tricyclic &dgr;3-piperidines as pharmaceuticals
US6172260B1 (en) 1998-12-31 2001-01-09 Eastman Kodak Company Preparation of high dye-yield couplers and intermediates useful therein
AR022228A1 (en) 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg TRIAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND USE OF THE SAME TO PREPARE SUCH COMPOSITION
JP2001288115A (en) * 2001-02-07 2001-10-16 Yamanouchi Pharmaceut Co Ltd Remedy for lower urinary tract symptom
WO2006065555A2 (en) * 2004-12-13 2006-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. Use of alpha-adrenergic blockers for the treatment of dysmenorrhea
US20220142914A1 (en) * 2018-10-17 2022-05-12 Austin Research Labs Corp. Suspension formulations of high load dispersions
CN110759878B (en) * 2019-10-29 2021-04-09 西安瑞联新材料股份有限公司 Synthetic method of phenyl tetrahydrofuran ether compound
TW202400018A (en) * 2022-06-21 2024-01-01 日商組合化學工業股份有限公司 Method for producing halogen derivatives using haloacetic acid
CN116768837A (en) * 2023-06-13 2023-09-19 常州大学 Benzopyran-2-one-based fluorescence chemical sensor and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888946A (en) * 1971-03-17 1975-06-10 Little Inc A Pyrano benzopyrans
US4117140A (en) * 1975-02-10 1978-09-26 Brown Richard E Bronchodilating piperidinoethyl benzopyranopyridinones
AU560459B2 (en) * 1982-06-01 1987-04-09 Abbott Laboratories Tetrahydro-benzo(e) isoindolines
FR2687146B1 (en) * 1992-02-12 1994-04-01 Adir Cie NOVEL PYRROLIDINE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Also Published As

Publication number Publication date
EP0942911A1 (en) 1999-09-22
TR199901883T2 (en) 1999-12-21
EP0942911B1 (en) 2001-10-17
SK283580B6 (en) 2003-09-11
CY2260B1 (en) 2003-07-04
DE69707497T2 (en) 2002-07-11
PT942911E (en) 2002-04-29
WO1998024791A1 (en) 1998-06-11
NO992661L (en) 1999-07-30
SK71799A3 (en) 2000-01-18
KR20000057418A (en) 2000-09-15
ATE207071T1 (en) 2001-11-15
CN1246861A (en) 2000-03-08
ES2168682T3 (en) 2002-06-16
AU735764B2 (en) 2001-07-12
NO992661D0 (en) 1999-06-02
CN1130365C (en) 2003-12-10
CZ194499A3 (en) 1999-11-17
CA2272330A1 (en) 1998-06-11
NZ335711A (en) 2000-10-27
DK0942911T3 (en) 2002-12-02
BG103553A (en) 2000-06-30
JP2002504088A (en) 2002-02-05
AU5516998A (en) 1998-06-29
BG63975B1 (en) 2003-08-29

Similar Documents

Publication Publication Date Title
DK0808318T3 (en) Tricyclic substituted hexahydrobenz [e] isoindole-alpha-1 adrenergic antagonists
DE69613347D1 (en) BIZYCLICALLY SUBSTITUTED HEXAHYDROBENZ (E) ISOINDOLE WITH ALPHA-1-ADRENERGIC ANTAGONISTIC EFFECT
DE69707497D1 (en) BENZOPYRANOPYRROLE AND BENZOPYRANOPYRIDINE WITH ALPHA-1 ADRENERGIC EFFECT
FI962489A0 (en) Morpholine and thiamorpholine tachykinin receptor antagonists
DK0807633T3 (en) Newly known 2,3-disubstituted (5,6) heteroaryl condensed pyrimidin-4-ones
NO984740L (en) Isatin derivatives such as acetylcholinesterase inhibitors and analgesics
NO954576D0 (en) AMPA antagonists and a method of treating them
MX9806171A (en) 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors.
DE69420738D1 (en) BICYCLIC HETEROCYCLES AS NEUROKININ A ANTAGONISTS
DE69819166D1 (en) 8-SUBSTITUTED-9H-1,3-DIOXOLO / 4,5-H // 2,3 / BENZODIAZEPINE DERIVATIVES AS AMPA / CAINATE RECEPTOR INHIBITORS
ES2149984T3 (en) IMIDAZOLY ALKYL DERIVATIVES OF IMIDAZOL (5,1-C) (1,4) BENZOXAZIN-1-ONA AND ITS USE AS THERAPEUTIC AGENTS.
AP9801410A0 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists.
BR9713682A (en) Alpha-1 adrenergic compounds of benzopyranopyrrole and benzopyranopyridine
ES8604843A1 (en) Acetylene derivatives for the treatment of hypertension and angina.
NZ520805A (en) Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
DE69903930D1 (en) N-ARYLOXYETHYL-INDOLYL-ALKYLAMINE FOR TREATING DEPRESSIONS
ATE265453T1 (en) DIKETOPIPERAZINE DERIVATIVES AS THROMBIN INHIBITORS

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee